Health Economics and Policy

Sitting Down With… Lucy Mathen, BBC journalist-turned-ophthalmologist – and founder of the charity Second Sight

With a growing armamentarium for glaucoma, balancing safety and efficacy is the modern-day challenge

Everything you need to know about SARS-CoV-2 and the COVID-19 pandemic

A round-up of novel coronavirus-related stories

With the pandemic putting frontline health workers under mounting pressure, is it possible for ophthalmologists to safely see patients?

The glaucoma subspecialty is now at a turning point, but new approaches, including MIGS, must be based on high-quality evidence

The DARPin platform has the AMD and DME treatment burden firmly in its sights – but that’s only the beginning

Organ-to-cloud technology is here – and it has its sights set on glaucoma

How important is a joint-up approach to caring for patients with diabetes and diabetic eye disease?

Clark E. Tedford tells us about his part in creating LumiThera, its flagship product and technology, and the company’s plans for the future